Difficulty: Medium
Average Score: 64%
Practice
A 62-year-old woman with type 2 diabetes, hypertension, renal impairment (creatinine 146 μmol/L) and mild congestive cardiac failure has poor diabetic control (HbA1c = 10.5 per cent), despite treatment with maximum doses of a sulfonylurea. Her body mass index (BMI) is 26. Which of the following would be most appropriate pharmacotherapy?
Correct answer
A
Rationale
Poor glycemic control (HbA1c 10.5%) despite max sulfonylurea in type 2 diabetes with renal impairment and CHF needs escalation. Insulin replaces sulfonylurea, offering precise control without renal clearance issues, most appropriate here. Rosiglitazone risks fluid retention, worsening CHF. Bisoprolol, a beta-blocker, and rimonabant (withdrawn) don't address glycemia. Metformin is contraindicated with creatinine 146 μmol/L (eGFR <30-45) due to lactic acidosis risk. Insulin's flexibility and safety in this complex case optimize outcomes, critical for reducing complications.